Point State Capital LP Biogen Inc. Transaction History

Point State Capital LP

$5.69 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $4.07 Million - $5.13 Million	-21,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $9.96 Million - $12.8 Million	-44,500 Reduced 67.94%	21,000 $5.04 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $7.05 Million - $9.19 Million	24,900 Added 61.33%	65,500 $18.5 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $1.76 Million - $2.82 Million	-6,800 Reduced 14.35%	40,600 $14.1 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $9.45 Million - $11.1 Million	38,900 Added 457.65%	47,400 $13.3 Million

Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.01 Million - $3.02 Million	8,500 New	8,500 $2.08 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $15.1 Million - $17.4 Million	-56,995 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $14.7 Million - $19.5 Million	56,995 New	56,995 $15.2 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $26.6 Million - $33.7 Million	-98,887 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $21.8 Million - $30.1 Million	98,887 New	98,887 $29.3 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $986,805 - $1.09 Million	-4,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $975,195 - $1.53 Million	4,500 New	4,500 $1.06 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $25.5 Million - $33.4 Million	-86,900 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $15.6 Million - $18.5 Million	-60,405 Reduced 41.01%	86,900 $25.2 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $162 Million - $228 Million	-620,912 Reduced 80.83%	147,305 $40.3 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $152 Million - $170 Million	493,787 Added 179.93%	768,217 $245 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $33.3 Million - $39.1 Million	118,500 Added 76.0%	274,430 $85.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	155,930	155,930 $42.3 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.74 Billion
0.07% of portfolio
Primecap Management CO Pasadena, CA

16.2M
Shares

$3.66 Billion
2.65% of portfolio
Black Rock Inc. New York, NY

14.1M
Shares

$3.19 Billion
0.07% of portfolio
State Street Corp Boston, MA

6.75M
Shares

$1.52 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.17M
Shares

$1.17 Billion
0.68% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Account